Akso Health Group Sponsored ADR (NASDAQ:AHG – Get Free Report)’s share price dropped 8% on Wednesday . The company traded as low as $1.93 and last traded at $1.95. Approximately 184,506 shares traded hands during trading, an increase of 92% from the average daily volume of 96,260 shares. The stock had previously closed at $2.12.
Analyst Ratings Changes
AHG has been the subject of a number of recent research reports. Weiss Ratings restated a “sell (d-)” rating on shares of Akso Health Group in a research note on Monday, April 20th. Wall Street Zen upgraded Akso Health Group to a “sell” rating in a research note on Saturday, May 2nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of “Sell”.
Get Our Latest Report on Akso Health Group
Akso Health Group Stock Down 9.0%
Institutional Trading of Akso Health Group
A hedge fund recently bought a new stake in Akso Health Group stock. SmartHarvest Portfolios LLC bought a new stake in shares of Akso Health Group Sponsored ADR (NASDAQ:AHG – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 16,748 shares of the company’s stock, valued at approximately $27,000. Hedge funds and other institutional investors own 1.21% of the company’s stock.
Akso Health Group Company Profile
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.
Featured Articles
- Five stocks we like better than Akso Health Group
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Akso Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akso Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
